Cholera

• 1. Introduction

  ›

  Cholera, caused by the bacterium Vibrio cholerae, has the power to kill an untreated person within hours. A healthy adult can lose ten to twenty litres of fluid in a single day. The skin turns bluish-grey from extreme fluid loss, which is why the disease earned the grim nickname the "blue death". Sunken eyes, cold clammy hands, and a pulse that grows rapid and threadlike follow in quick succession. Muscle cramps can persist even after death.

  Seven cholera pandemics have swept the globe since the early 19th century. The most recent began in 1961, in Indonesia, and it is still running today. The bacterium continues to infect an estimated two to five million people worldwide each year, and kills tens of thousands. Where treatment is unavailable, the mortality rate can reach fifty to sixty percent. Where it is available, that figure drops below one percent.

  How does a microbe achieve such devastation so fast? What does it actually do inside the body? And why, after nearly two centuries of scientific understanding, does cholera still menace entire nations? Those are the questions this documentary sets out to answer.

• 2. A Body Under Siege

  ›

  The diarrhea of cholera is described by physicians as "rice water" in nature and may carry a fishy odor. That phrase understates the crisis it creates. An untreated person can lose fluids at a rate the body cannot survive for long. Blood pressure drops, peripheral pulses grow rapid and thready, and urine output decreases steadily with time.

  The catastrophe begins in the small intestine. Surviving bacteria, after passing through the acid of the stomach, propel themselves through thick mucus lining the intestinal wall. Once anchored to the wall, they shift their protein production entirely, and begin manufacturing the cholera toxin. That toxin is an oligomeric complex with six protein subunits: one A subunit and five B subunits, joined by a disulfide bond. The five B subunits bind to GM1 gangliosides on the surface of intestinal cells, the complex is drawn inside, and then the A1 subunit is freed to permanently alter a G protein.

  The downstream effect is constitutive production of cyclic AMP, which drives the secretion of water, sodium, potassium, and bicarbonate into the lumen of the small intestine. The resulting salt-water environment pulls up to six litres of water per day through the intestinal cells by osmosis. That flood of fluid is the "rice water" pouring out of the patient.

  Fever is rare in cholera and, when present, signals a secondary infection. The electrolyte chaos that follows severe dehydration produces muscle cramping, altered consciousness, seizures, and, in children especially, coma. Kussmaul breathing, a deep and labored pattern, can emerge from the acidosis that builds as bicarbonate is lost.

• 3. How the Bacterium Travels

  ›

  A single diarrheal episode from a cholera patient can cause a one-million-fold increase in V. cholerae numbers in the surrounding environment. That arithmetic explains how quickly the disease can overwhelm a community once clean water is compromised.

  Transmission follows the fecal-oral route: contaminated water and food carry the bacterium to a new host. Developed countries tend to see transmission through food, while in developing countries contaminated water is the more common path. Shellfish are a particular risk because V. cholerae accumulates in planktonic crustaceans, and oysters eating that zooplankton concentrate the bacteria in their tissues.

  The bacterium does not need a human host to persist. It lives naturally in water sources, interacting with phytoplankton, zooplankton, and other aquatic matter. Selective pressure in the aquatic environment does reduce its virulence: one study found that the bacteria's ability to be cultured on standard media dropped ninety percent within twenty-four hours of entering the water, and that loss in culturability was paired with a loss in virulence.

  Non-toxic strains can acquire toxicity through a temperate bacteriophage. Specifically, virulent strains carry a variant of a bacteriophage called CTX-phi, and the gene encoding the cholera toxin was introduced into V. cholerae by horizontal gene transfer. Climate change is increasing the occurrence, distribution, and intensity of cholera outbreaks, extending the reach of this ancient disease.

• 4. Who Is Most at Risk

  ›

  About one hundred million bacteria must typically be ingested to cause cholera in a normal healthy adult. That threshold is lower for people using proton pump inhibitors, which reduce stomach acidity, and lower still for children. Two- to four-year-olds carry the highest infection rates of any age group.

  Blood type also matters. People with type O blood are the most susceptible to severe cholera, while those who are malnourished or immunocompromised face a sharply elevated risk of developing a severe case. Persons with AIDS fall into that category.

  There is an unexpected genetic dimension to susceptibility. The cystic fibrosis mutation known as delta-F508 appears to confer a selective advantage in heterozygous carriers who do not themselves have cystic fibrosis. The deficiency in the cystic fibrosis transmembrane conductance regulator channel proteins interferes with bacteria binding to the intestinal epithelium, making those carriers more resistant to V. cholerae infection. The observation has led researchers to speculate about why this mutation persisted in human populations over generations.

  Even a healthy adult in middle age can suffer a severe case. The key variable is how quickly fluid loss is recognized and corrected; every case should be measured by the volume of fluids lost, rather than by any assumption about the patient's underlying fitness.

• 5. Treatment and Prevention

  ›

  The most common error in caring for cholera patients is underestimating the speed and volume of fluids required. Oral rehydration therapy addresses that deficit directly: a slightly sweet and salty solution that replaces fluids and electrolytes. Rice-based solutions are preferred over glucose-based ones because of greater efficiency. In children, zinc supplementation reduced the duration of diarrhea by eight hours and the amount of diarrheal stool by ten percent in Bangladesh trials.

  For severe cases, intravenous rehydration with Ringer's lactate is the preferred intervention. Ten percent of a patient's body weight in fluid may need to be administered in the first two to four hours. This approach was tested on a mass scale during the Bangladesh Liberation War and proved highly effective. Fruit juices and commercial fizzy drinks are not suitable substitutes; their excessive sugar content may actually impair water uptake.

  Antibiotic treatment for one to three days shortens the disease course and reduces fluid requirements. Doxycycline is typically used first, though resistance is increasing. In Bangladesh, most cases are now resistant to tetracycline, trimethoprim-sulfamethoxazole, and erythromycin. The WHO recommends antibiotics only for those with severe dehydration.

  For prevention, boiling and chlorination of water remain the least expensive and most effective tools. In Bangladesh, folding a used sari four to eight times as a water filter was found to decrease cholera rates by nearly half. The repeated washing that comes with use reduces the space between the fibers, making used cloth more effective than new cloth. Oral cholera vaccines exist; the WHO has prequalified three, named Dukoral, Sanchol, and Euvichol. Dukoral carries an overall efficacy of about fifty-two percent in the first year after administration and sixty-two percent in the second year.

• 6. Science Catching Up

  ›

  John Snow, born in 1813, is often called the Father of Epidemiology for work he conducted in London in 1854. In two field studies that year, he demonstrated that human sewage contamination was the most probable vector in two major London epidemics. His map of cases was the first recorded instance of epidemiological tracking. Snow had proposed a microbial origin for the disease as early as 1849, but his model was not widely accepted until medical microbiology developed over the following three decades.

  The bacterium itself was isolated in 1854 by Italian anatomist Filippo Pacini, though his results were not widely known. In the same year, the Catalan researcher Joaquim Balcells i Pascual made the same discovery independently. Robert Koch confirmed V. cholerae with a microscope as the causative bacterium in 1883.

  Hemendra Nath Chatterjee, a Bengali scientist, was the first to formulate oral rehydration salts as a treatment for diarrhea. His 1953 paper in The Lancet showed that promethazine could stop vomiting during cholera, making oral rehydration possible. His formulation called for four grams of sodium chloride, twenty-five grams of glucose, and one thousand millilitres of water. Indian medical scientist Sambhu Nath De discovered the cholera toxin and the animal model of cholera, and demonstrated the method of transmission of the pathogen.

  Robert Allan Phillips, working at US Naval Medical Research Unit Two in Southeast Asia, evaluated the pathophysiology of the disease using modern laboratory chemistry and developed a rehydration protocol. The Lasker Foundation awarded him its prize in 1967. Research published in 2002 by Alam and colleagues at the International Centre for Diarrhoeal Disease in Dhaka found that V. cholerae passing through the human digestive system enters a hyperinfected state just before defecation, with genes controlling amino acid biosynthesis and iron uptake induced to help the bacteria survive in the oxygen-poor, iron-limited environment of the stool.

• 7. Seven Pandemics

  ›

  The first cholera pandemic began in the Bengal region of India, near Calcutta, in 1817 and lasted until 1824. British Army and Navy ships are believed to have extended its reach from Africa to Indonesia and north to China and Japan. The second pandemic, from 1826 to 1837, killed one hundred and fifty thousand Americans. The third erupted in 1846 and introduced the disease to Brazil for the first time; it reached North America through Irish immigrants at Quebec, Canada, driven there by the Great Famine.

  The fourth pandemic, lasting from 1863 to 1875, entered the United States at New Orleans, Louisiana, in 1873 and spread through the Mississippi River system. Germany's Hamburg suffered a severe outbreak in 1892 in which more than eight thousand six hundred people died. In Russia alone, between 1847 and 1851, more than one million people died from the disease. Between 1900 and 1920, perhaps eight million people died of cholera in India.

  The seventh pandemic originated in Indonesia in 1961 with a new strain nicknamed El Tor. It was thought to have subsided around 1975, but it persisted. The worst recent outbreak declared by the WHO was in Yemen: in 2019, ninety-three percent of the reported nine hundred and twenty-three thousand, thirty-seven cholera cases globally came from that one war-ravaged country, with one thousand nine hundred and eleven deaths reported.

  In 2017, the WHO launched a strategy called "Ending Cholera: a global roadmap to 2030", aiming to reduce cholera deaths by ninety percent by 2030. The Global Task Force on Cholera Control, which developed the strategy, targets forty-seven countries, thirteen of which have established vaccination campaigns. The WHO does not consider global eradication achievable, because V. cholerae can persist in the environment without a human host, but local elimination remains possible.